# IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis

> **NCT02241512** · PHASE2 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 69 (actual)

## Conditions studied

- Post-ERCP Acute Pancreatitis

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02241512
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 69 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02241512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02241512, "IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02241512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*